Proteome Sciences plc (LON:PRM – Get Free Report)’s share price shot up 3.4% during mid-day trading on Friday . The company traded as high as GBX 5 ($0.06) and last traded at GBX 4.64 ($0.06). 485,157 shares were traded during mid-day trading, an increase of 165% from the average session volume of 183,230 shares. The stock had previously closed at GBX 4.49 ($0.06).
Proteome Sciences Price Performance
The business’s 50 day moving average is GBX 3.84 and its two-hundred day moving average is GBX 3.26. The firm has a market capitalization of £13.71 million, a PE ratio of -3.36 and a beta of 0.07. The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- The How And Why of Investing in Oil Stocks
- Palantir Stock Skids—How Much Further Can It Fall?
- What is the FTSE 100 index?
- Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?
- Why Are Stock Sectors Important to Successful Investing?
- 2 S&P 500 ETFs for Growth and Leverage in a Hot Market
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
